157 related articles for article (PubMed ID: 16990079)
1. The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.
Sakamoto K; Sakamoto T; Ogawa H;
Clin Ther; 2006 Jul; 28(7):1012-21. PubMed ID: 16990079
[TBL] [Abstract][Full Text] [Related]
2. Effects of increasing the dose of pravastatin on serum adiponectin level in Japanese mild hypercholesterolemic and hypertensive patients.
Kai T; Kanamasa K
Arzneimittelforschung; 2009; 59(9):445-50. PubMed ID: 19856791
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
5. Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
Koh KK; Lim S; Choi H; Lee Y; Han SH; Lee K; Oh PC; Sakuma I; Shin EK; Quon MJ
Diabetes; 2013 Oct; 62(10):3547-52. PubMed ID: 23863812
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
[TBL] [Abstract][Full Text] [Related]
7. Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus.
Kim JH; Lee MR; Shin JA; Lee SS; Lee JM; You SJ; Yoon KH; Chang SA
Atherosclerosis; 2013 Apr; 227(2):355-9. PubMed ID: 23466100
[TBL] [Abstract][Full Text] [Related]
8. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
[TBL] [Abstract][Full Text] [Related]
9. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
11. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
[TBL] [Abstract][Full Text] [Related]
12. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group.
Cobbaert C; Jukema JW; Zwinderman AH; Withagen AJ; Lindemans J; Bruschke AV
J Am Coll Cardiol; 1997 Nov; 30(6):1491-9. PubMed ID: 9362407
[TBL] [Abstract][Full Text] [Related]
13. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
[TBL] [Abstract][Full Text] [Related]
15. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
16. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
Yokoyama M; Origasa H;
Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
[TBL] [Abstract][Full Text] [Related]
17. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
Richter WO; Jacob BG; Schwandt P
Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia. The evidence supports use of statins.
Aronow WS
Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
[TBL] [Abstract][Full Text] [Related]
20. Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.
Koh KK; Quon MJ; Han SH; Lee Y; Kim SJ; Park JB; Shin EK
Atherosclerosis; 2009 Jun; 204(2):483-90. PubMed ID: 18977478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
